inhibitors for the treatment of erectile dysfunction

Seven years of PDE-5 inhibitors for the treatment of erectile dysfunction
Sildenafil revolutionized its market entry in 1998, the treatment of
erectile dysfunction. It is still the best selling product in its drug
class. Its unique history and location make the impressive data for
the drug sildenafil, physicians and scientists exciting. In addition,
the substance stimulates further investigations on - even in
therapeutic areas outside of erectile dysfunction pills.

Viagra ® by doctors and researchers around the world were motivated to
want to understand the reasons behind sexual dysfunction and better
treatment options to improve further. Seven years after its
introduction, the most famous place among the PDE-5 inhibitors is
widely accepted by primary care physicians and urologists.

The positive practical experience with sildenafil treatment are
supported by results from more than 130 clinical trials. National and
international studies at more than 43,000 patients to document the
efficacy and tolerability. Surveys of users have also shown that
treatment with Viagra pills, the male fulfilled expectations. Even the
women were shown in order to ask-satisfied with the treatment results
of their partners.

For not only benefit the victims themselves physically and mentally
from the treatment: A recent study by Raymond Rosen shows, through a
successful ED therapy also improved partnership, family life and
quality of life significantly.

More astonishing is that - are erectile dysfunction undertreated and
underdiagnosed still - despite the large presence of the topic
sexuality in everyday life. As before, there are men involved in the
high barriers to address the issue openly. In Germany alone, experts
estimate five million men with erectile dysfunction, but of which only
about one in four speaks to his doctor. Erection problems are
perceived differently by each man. But even mild or occasional
impairment of erectile function may trigger a high subjective
distress. This is often accompanied by uncertainty and fear of failure
which discourage the individuals to whom to entrust themselves to
their partner or doctor.

Pfizer assumes its responsibilities as a pioneer in the field of
sexual health and is particularly active in educational work. This
takes the initiative, "Body & Soul man" on the wishes and needs for an
open and positive approach. The aim is to encourage such men to ask
for a solution to their problem. At the same doctors to help is
offered for patient education in order to more easily get into the
sensitive subject of sexuality can. Erectile dysfunction should be
taken so forth out of the taboo zone to open up people the opportunity
to get a sex life and an improved quality of life.